AVRICORE HEALTH INC (AVCR.CA) Fundamental Analysis & Valuation

TSX-V:AVCR • CA0545211090

Current stock price

0.07 CAD
0 (0%)
Last:

This AVCR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AVCR.CA Profitability Analysis

1.1 Basic Checks

  • In the past year AVCR has reported negative net income.
  • AVCR had a negative operating cash flow in the past year.
  • In the past 5 years AVCR always reported negative net income.
  • In multiple years AVCR reported negative operating cash flow during the last 5 years.
AVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFAVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M -4M

1.2 Ratios

  • With a Return On Assets value of -122.49%, AVCR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • AVCR has a Return On Equity of -125.89%. This is comparable to the rest of the industry: AVCR outperforms 60.00% of its industry peers.
Industry RankSector Rank
ROA -122.49%
ROE -125.89%
ROIC N/A
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVCR.CA Yearly ROA, ROE, ROICAVCR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • AVCR has a Gross Margin (43.48%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of AVCR has declined.
  • The Profit Margin and Operating Margin are not available for AVCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
AVCR.CA Yearly Profit, Operating, Gross MarginsAVCR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

8

2. AVCR.CA Health Analysis

2.1 Basic Checks

  • AVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AVCR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AVCR has more shares outstanding
  • There is no outstanding debt for AVCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AVCR.CA Yearly Shares OutstandingAVCR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AVCR.CA Yearly Total Debt VS Total AssetsAVCR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

  • AVCR has an Altman-Z score of 91.01. This indicates that AVCR is financially healthy and has little risk of bankruptcy at the moment.
  • AVCR's Altman-Z score of 91.01 is fine compared to the rest of the industry. AVCR outperforms 80.00% of its industry peers.
  • AVCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 91.01
ROIC/WACCN/A
WACC8.64%
AVCR.CA Yearly LT Debt VS Equity VS FCFAVCR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

2.3 Liquidity

  • A Current Ratio of 17.92 indicates that AVCR has no problem at all paying its short term obligations.
  • AVCR has a better Current ratio (17.92) than 100.00% of its industry peers.
  • AVCR has a Quick Ratio of 17.81. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of AVCR (17.81) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 17.92
Quick Ratio 17.81
AVCR.CA Yearly Current Assets VS Current LiabilitesAVCR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2

3. AVCR.CA Growth Analysis

3.1 Past

  • The earnings per share for AVCR have decreased strongly by -1820.00% in the last year.
  • AVCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -59.28%.
  • The Revenue has been growing by 170.57% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
Revenue 1Y (TTM)-59.28%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-96.85%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVCR.CA Yearly Revenue VS EstimatesAVCR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

0

4. AVCR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AVCR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVCR.CA Price Earnings VS Forward Price EarningsAVCR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVCR.CA Per share dataAVCR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. AVCR.CA Dividend Analysis

5.1 Amount

  • No dividends for AVCR!.
Industry RankSector Rank
Dividend Yield 0%

AVCR.CA Fundamentals: All Metrics, Ratios and Statistics

AVRICORE HEALTH INC

TSX-V:AVCR (3/13/2026, 7:00:00 PM)

0.07

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-01
Earnings (Next)04-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.94%
Ins Owner ChangeN/A
Market Cap7.09M
Revenue(TTM)1.92M
Net Income(TTM)-1.63M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.69
P/FCF N/A
P/OCF N/A
P/B 5.48
P/tB 5.8
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -122.49%
ROE -125.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.48%
FCFM N/A
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
F-Score4
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 47.74%
Cap/Sales 6.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.92
Quick Ratio 17.81
Altman-Z 91.01
F-Score4
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)316.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)34.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-59.28%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-96.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-890.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-137.82%
OCF growth 3YN/A
OCF growth 5YN/A

AVRICORE HEALTH INC / AVCR.CA Fundamental Analysis FAQ

What is the fundamental rating for AVCR stock?

ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA.


Can you provide the valuation status for AVRICORE HEALTH INC?

ChartMill assigns a valuation rating of 0 / 10 to AVRICORE HEALTH INC (AVCR.CA). This can be considered as Overvalued.


Can you provide the profitability details for AVRICORE HEALTH INC?

AVRICORE HEALTH INC (AVCR.CA) has a profitability rating of 1 / 10.


How financially healthy is AVRICORE HEALTH INC?

The financial health rating of AVRICORE HEALTH INC (AVCR.CA) is 8 / 10.